Clinical and Functional Criteria for the Vital Activity of Patients and Disabled People Suffering from Presbyopia

The purpose: to evaluate the therapeutic effect of Quinax, administered by the method of triple instillations for 6 months to patients with presbyopia in order to determine its effect on the development of refractive errors in this category of patients. Patients and methods. The treatment was carried out in 60 patients with an average age of 43 ± 2 years, suffering from presbyopia. At the same time, the main group consisted of 30 patients who were treated with Quinax when it was administered by the method of triple instillations for 12 months. The comparison group consisted of 30 people who underwent treatment of presbyopia by other conservative methods. Each patient underwent an ophthalmological examination, which included: visometry, perimetry, refractometry, biomicroscopy, ophthalmoscopy, visual performance study, dark adaptation, and complaints were analyzed in order to establish their impact on the quality of life in patients and disabled people with cataracts and presbyopia. Results. The results of the study showed the effectiveness of the use of Quinax when administered by the method of three instillations for 12 months and revealed stabilization of changes in visual acuity and visual field to white, red and green colors, reduction of visual fatigue due to reduction of glare, stabilization of dark adaptation and refraction. Conclusion. From the above research data, it can be seen that treatment with Quinax drops gives positive results both functionally and subjectively. The results obtained during the study provide the basis for the recommendation of the drug “Quinax” to all patients with presbyopia.

1. Grzybowski A, Ruamviboonsuk V. Pharmacological Treatment in Presbyopia. J Clin Med. 2022 Mar 3;11(5):1385. doi: 10.3390/jcm11051385.

2. Instructions for the medicinal product Quinax LP-008536 (In Russ.).

3. Fisher RF. The significance of the shape of the lens and capsular energy changes in accommodation. J Physiol. 1969 Mar;201(1):21–47. doi: 10.1113/jphysiol.1969.sp008740.

4. Glasser A, Campbell MC. Biometric, optical and physical changes in the isolated human crystalline lens with age in relation to presbyopia. Vision Res. 1999 Jun; 39(11):1991–2015. doi: 10.1016/s0042-6989(98)00283-1.

5. Strenk SA, Semmlow JL, Strenk LM, Munoz P, Gronlund-Jacob J, DeMarco JK. Age-related changes in human ciliary muscle and lens: a magnetic resonance imaging study. Invest Ophthalmol Vis Sci. 1999 May;40(6):1162–1169.

6. Judge SJ, Burd HJ. Modelling the mechanics of accommodation and presbyopia. Ophthalmic Physiol Opt. 2002 Sep;22(5):397–400. doi: 10.1046/j.1475-1313.2002.00065.x.

7. Fisher RF. The elastic constants of the human lens. J Physiol. 1971 Jan;212(1):147–180. doi: 10.1113/jphysiol.1971.sp009315.

8. Heys KR, Cram SL, Truscott RJ. Massive increase in the stiffness of the human lens nucleus with age: the basis for presbyopia? Mol Vis. 2004 Dec 16;10:956–963.

9. Kuszak JR, Zoltoski RK.The mechanism of accommodation at the lens fiber level. In Ioselaini OR ed. Focus on Eye Research. New York, NY: Nova Science Publishers, Inc.; 2005:117–133.

10. Garner WH, Garner MH. Protein Disulfide Levels and Lens Elasticity Modulation: Applications for Presbyopia. Invest Ophthalmol Vis Sci. 2016 May 1;57(6):2851– 2863. doi: 10.1167/iovs.15-18413.

11. Lou MF, Dickerson JE. Protein-thiol mixed disulfides in human lens. Exp Eye Res. 1992;55:889–896.

12. Bova LM, Sweeney MH, Jamie JF, Truscott RJ. Major changes in human ocular UV protection with age. Invest Ophthalmol Vis Sci. 2001 Jan;42(1):200–205.

13. Zuo H, Cheng H, Lin M, Gao X, Xiang Y, Zhang T, Gao N, Du M, Chen Y, Zheng S, Huang R, Wan W, Hu K. The effect of aging on the ciliary muscle and its potential relationship with presbyopia: a literature review. PeerJ. 2024 Dec 24;12:e18437. doi: 10.7717/peerj.18437.

14. Avetisov SE, Shitikova AV, Avetisov KS. Anatomical, morphological and biomechanical aspects of accommodation. Russian Annals of Ophthalmology. 2022;138(4):117–125 (In Russ.). doi: 10.17116/oftalma2022138041117.

15. Bentley S, Findley A, Chiva-Razavi S, Naujoks C, Patalano F, Johnson C, Arbuckle R, Wolffsohn JS. Understanding the visual function symptoms and associated functional impacts of phakic presbyopia. J Patient Rep Outcomes. 2021 Nov 3; 5(1):114. doi: 10.1186/s41687-021-00383-1.